InvestorsHub Logo
Followers 24
Posts 335
Boards Moderated 0
Alias Born 10/11/2020

Re: Mutat post# 158715

Wednesday, 09/07/2022 9:28:30 AM

Wednesday, September 07, 2022 9:28:30 AM

Post# of 198218
“Enzolytics, a Texas-based maker of monoclonal antibody drugs, has inked a deal with Samsung Biologics to support and manufacture its investigational new drug treatments for HIV and COVID-19.

Financial terms of the deal with the South Korean CMO giant weren’t disclosed. Samsung will manufacture a stable cell line with support from its R&D facility in San Francisco, while related clinical trial materials will be produced at its sprawling facility in Incheon, South Korea.”